Detalhe da pesquisa
1.
Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world: The retrospective IMAGE study.
Eur J Haematol;
2024 May 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38712850
2.
Pomalidomide and dexamethasone until progression after first salvage therapy in multiple myeloma.
Br J Haematol;
201(6): 1103-1115, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36974007
3.
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial.
Lancet Oncol;
22(10): 1378-1390, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34529931
4.
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.
Lancet;
394(10192): 29-38, 2019 07 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31171419
5.
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma.
Blood;
132(24): 2555-2563, 2018 12 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30282798
6.
Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study.
Haematologica;
106(8): 2257-2260, 2021 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33657786
7.
EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition.
Nat Commun;
15(1): 3452, 2024 Apr 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38658543
8.
Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging.
Radiology;
254(2): 521-31, 2010 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20093523
9.
Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
Clin Infect Dis;
48(8): 1042-51, 2009 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19281327
10.
Risk factors for severe infection in patients with hairy cell leukemia: a long-term study of 73 patients.
Eur J Haematol;
83(3): 246-50, 2009 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19302557
11.
Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial.
Clin Cancer Res;
25(14): 4224-4230, 2019 07 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31053600
12.
PET/CT imaging in management of concomitant Hodgkin lymphoma and tuberculosis - a problem solver tool.
Clin Case Rep;
6(1): 232-234, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29375875
13.
Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma.
Leukemia;
36(3): 881-884, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34650225
14.
Sinusoidal obstruction syndrome: a warning about autologous stem cell transplantation preceded by regimens containing oxaliplatin.
Bone Marrow Transplant;
55(9): 1834-1836, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31959893
15.
Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study.
Invest Radiol;
46(5): 341-9, 2011 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21263330
16.
[Management of drug-induced agranulocytosis]. / Agranulocytose médicamenteuse: conduite à tenir.
Rev Prat;
55(6): 671-5, 2005 Mar 31.
Artigo
em Francês
| MEDLINE
| ID: mdl-15913122
17.
[Indications of G-CSF administration in hematologic disorders]. / Indications des facteurs de croissance granulocytaires en hématologie.
Bull Cancer;
93(5): 453-62, 2006 May.
Artigo
em Francês
| MEDLINE
| ID: mdl-16777623